argenx SE
NASDAQ:ARGX · NASDAQ Global Select
-$14.57 today
Vol 0.35M · Avg 0.33M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+62.31%
Period High
$929.61
Period Low
$538.64
Latest
$877.72
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Regeneron Pharmaceuticals, Inc.
NASDAQ:REGN
$62.08B
Becton, Dickinson and Company
NYSE:BDX
$52.13B
Cardinal Health, Inc.
NYSE:CAH
$52.10B
Edwards Lifesciences Corporation
NYSE:EW
$50.17B
IDEXX Laboratories, Inc.
NASDAQ:IDXX
$44.01B
Haleon plc
NYSE:HLN
$39.53B
Alnylam Pharmaceuticals, Inc.
NASDAQ:ALNY
$36.87B
Agilent Technologies, Inc.
NYSE:A
$35.94B
Alcon Inc.
NYSE:ALC
$31.50B
Veeva Systems Inc.
NYSE:VEEV
$24.74B
What is the latest ARGX filing?
The latest filing shown is 6-K dated Jun 3, 2026.
How many recent filings does ARGX have?
Intrinsic Alpha currently shows 20 recent filings for ARGX.
Explore More
Continue the stock analysis
Jump to another research area for this company.